Robin Freestone - Smith Nephew Non-Executive Director

SNNUF Stock  USD 11.66  0.73  5.89%   

Director

Mr. Robin Anthony David Freestone is Senior NonExecutive Independent Director of the Company effective 11 April 2019. He is a Member of the Audit Committee and the Remuneration Committee in September 2015 and Chair of the Audit Committee in April 2017. Robin will succeed Ian Barlow as Senior Independent Director following the AGM on 11 April 2019 and join the Nomination Governance Committee. Career and experience Robin graduated with a BA in Economics from The University of Manchester and later qualified and commenced his career as a Chartered Accountant at Deloitte. He has held a number of senior financial positions throughout his career, including at ICI plc, Henkel Ltd and at Amersham plc. Robin was the Deputy CFO and then later the CFO of Pearson plc between 2006 and August 2015, where he was heavily involved with the transformation and diversification of Pearson. He was previously NED at eChem Ltd, Chair of the 100 Group and Senior Independent Director and Chair of the Audit Committee of Cable Wireless Communications plc. Robin is NED and Chair of the Audit Committee at Capri Holdings Ltd, . Robin became Chair of the ICAEW Corporationrationrate Governance Committee in 2017 and is currently a NED and Chair of the Audit Committee at MoneySupermarket.com plc. Robin will be appointed as Chair of their Board with effect from the conclusion of its Annual General Meeting on 9 May 2019. Skills and competencies Robin was a wellregarded FTSE 100 CFO who has not only been heavily involved with transformation and diversification, but also the healthcare industry at Amersham, where his acquisition experience is of value to Smith Nephew as it continues to grow globally and in different markets. He brings financial expertise and insight as Chair of the Audit Committee and an understanding of how to attract and retain talent in a global business as a member of the Remuneration Committee. since 2019.
Age 59
Tenure 5 years
Phone44 1923 477 100
Webhttps://www.smith-nephew.com

Smith Nephew Management Efficiency

The company has return on total asset (ROA) of 0.0425 % which means that it generated a profit of $0.0425 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0925 %, meaning that it generated $0.0925 on every $100 dollars invested by stockholders. Smith Nephew's management efficiency ratios could be used to measure how well Smith Nephew manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 2.71 B in total debt with debt to equity ratio (D/E) of 0.54, which is about average as compared to similar companies. Smith Nephew plc has a current ratio of 1.74, which is within standard range for the sector. Debt can assist Smith Nephew until it has trouble settling it off, either with new capital or with free cash flow. So, Smith Nephew's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Smith Nephew plc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Smith to invest in growth at high rates of return. When we think about Smith Nephew's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Elizabeth NabelMedtronic PLC
69
Carl FlorioParagon 28
64
Randall HoganMedtronic PLC
64
Samuel RiccitelliOrthopediatrics Corp
59
Stephen BurnsOrthopediatrics Corp
74
Marie InfanteOrthopediatrics Corp
68
Olav BergheimGlaukos Corp
64
Roxanne CoadyParagon 28
64
Andrea GoldsmithMedtronic PLC
56
David PelizzonOrthopediatrics Corp
62
Charles FarkasCONMED
68
Donald SpenceInteger Holdings Corp
67
Hugh MorrisonLivaNova PLC
70
Susan HarnettParagon 28
57
Arthur RosenthalLivaNova PLC
70
Denise OLearyMedtronic PLC
62
Kendall PowellMedtronic PLC
66
Lisa ColleranAxogen Inc
59
Craig ArnoldMedtronic PLC
60
Bryan HughesOrthopediatrics Corp
40
Kristina WrightParagon 28
47
Smith Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. Smith Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom. Smith Nephew operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 18000 people. Smith Nephew plc [SNNUF] is a Pink Sheet which is traded between brokers as part of OTC trading.

Management Performance

Smith Nephew plc Leadership Team

Elected by the shareholders, the Smith Nephew's board of directors comprises two types of representatives: Smith Nephew inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Smith. The board's role is to monitor Smith Nephew's management team and ensure that shareholders' interests are well served. Smith Nephew's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Smith Nephew's outside directors are responsible for providing unbiased perspectives on the board's policies.
Namal Nawana, CEO, Executive Director
Michael Friedman, Non-Executive Independent Director
Diogo MoreiraRato, President - Europe and Canada
Alison Parkes, Chief Officer
Skip Kiil, President - Orthopedics
Erik Engstrom, Non-Executive Director
Deepak Nath, CEO Director
Matthew Stober, President - Global Operations
Marc Owen, Non-Executive Director
AnneFrancoise Nesmes, CFO Director
Helen Barraclough, Company Counsel
Rodrigo Bianchi, President IRAMEA
Brian Larcombe, Senior Independent Non-Executive Director
Elga Lohler, Chief Human Resource Officer
Bradley Cannon, Sports Orthopaedics
Gunthorp Oie, IR Contact Officer
Roland Diggelmann, Non-Executive Director
Helen Maye, Chief Human Resources Officer
Vinita Bali, Non-Executive Director
Simon Fraser, President - Advanced Wound Management
Massimiliano Colella, President Europe - Middle East and Africa
Olivier Bohuon, CEO, Director, Chairman of Disclosures Committee, Chairman of Executive Risk Committee and Member of Nomination and Governance Committee
Graham Baker, CFO, Executive Director
Cathy ORourke, Chief Legal and Compliance Officer
Roberto Quarta, Non-Executive Independent Chairman of the Board
Joe Metzger, VP Communications
Cyrille Petit, Chief Corporate Development Officer
Julie Brown, CFO, Director and Member of Disclosures Committee
Glenn Warner, President - Advanced Wound Management
Robin Freestone, Non-Executive Director
Paul Connolly, Pres Operations
Virginia Bottomley, Non-Executive Independent Director
Phil Cowdy, Executive Vice President of Business Development & Corporate Affairs
Angie Risley, Non-Executive Director
Mark Gladwell, President - Global Operations
Andrew Swift, VP Relations
Vasant Padmanabhan, President - Research & Development
Michael Frazzette, President - Advanced Surgical Devices
Joseph Papa, Non-Executive Independent Director
Ingeborg Oie, VP, Investor Relations
Susan Swabey, Company Secretary
Melissa Guerdan, Chief Quality and Regulatory Affairs Officer
Philip Cowdy, Chief Officer
Gordon Howe, President of Global Operations
John Campo, Chief Legal Officer
Brad Cannon, President Europe and Canada
Ian Barlow, Non-Executive Independent Director
Catheryn ORourke, Chief Legal Officer

Smith Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Smith Nephew a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Smith Nephew in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Smith Nephew's short interest history, or implied volatility extrapolated from Smith Nephew options trading.

Currently Active Assets on Macroaxis

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Smith Nephew plc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment.
You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Complementary Tools for Smith Pink Sheet analysis

When running Smith Nephew's price analysis, check to measure Smith Nephew's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Smith Nephew is operating at the current time. Most of Smith Nephew's value examination focuses on studying past and present price action to predict the probability of Smith Nephew's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Smith Nephew's price. Additionally, you may evaluate how the addition of Smith Nephew to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Bonds Directory
Find actively traded corporate debentures issued by US companies
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Equity Valuation
Check real value of public entities based on technical and fundamental data
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Please note, there is a significant difference between Smith Nephew's value and its price as these two are different measures arrived at by different means. Investors typically determine if Smith Nephew is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Smith Nephew's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.